Dannex Ayrton Starwin (XGHA:DASPHARMA) Other Long-Term Liabilities: GHS-0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:DASPHARMA Dannex Ayrton Starwin PLC XGHA:DASPHARMA
7 GF Score
Price GHS1.19
! 1 Warning Sign
View Full Analysis

What is Dannex Ayrton Starwin Other Long-Term Liabilities?

Dannex Ayrton Starwin XGHA:DASPHARMA -2.46% 7 Other Long-Term Liabilities is GHS-0.0 Mil as of Jun. 2026. GuruFocus rates XGHA:DASPHARMA with a GF Score™ of 7/100. The stock has 1 warning sign investors should review.

Dannex Ayrton Starwin's other long-term liabilities for the quarter that ended in Jun. 2026 was GHS-0.0 Mil.

Dannex Ayrton Starwin's quarterly other long-term liabilities increased from Dec. 2025 (GHS1.3 Mil) to Mar. 2026 (GHS1.3 Mil) but then declined from Mar. 2026 (GHS1.3 Mil) to Jun. 2026 (GHS-0.0 Mil).

Dannex Ayrton Starwin's annual other long-term liabilities declined from Dec. 2023 (GHS0.0 Mil) to Dec. 2024 (GHS0.0 Mil) but then increased from Dec. 2024 (GHS0.0 Mil) to Dec. 2025 (GHS1.3 Mil).

Dannex Ayrton Starwin Other Long-Term Liabilities Related Terms

Dannex Ayrton Starwin Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Dannex Ayrton Starwin's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dannex Ayrton Starwin Other Long-Term Liabilities Chart

Dannex Ayrton Starwin Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 0.00 -0.00 0.00 0.00 1.32

Dannex Ayrton Starwin Quarterly Data
Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 1.32 1.34 -0.00
XGHA:DASPHARMA
7GF Score
Dannex Ayrton Starwin PLC XGHA:DASPHARMA
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dannex Ayrton Starwin Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of GHS-0.0 Mil mean?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a Other Long-Term Liabilities of GHS-0.0 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dannex Ayrton Starwin and its competitors.
Is Dannex Ayrton Starwin's Other Long-Term Liabilities too high?
Dannex Ayrton Starwin's current Other Long-Term Liabilities is GHS-0.0 Mil. Overall, Dannex Ayrton Starwin has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Dannex Ayrton Starwin's Other Long-Term Liabilities compare to ?
Dannex Ayrton Starwin's Other Long-Term Liabilities of GHS-0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dannex Ayrton Starwin and its competitors. Dannex Ayrton Starwin's current Other Long-Term Liabilities is GHS-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dannex Ayrton Starwin stock overvalued right now?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a current Other Long-Term Liabilities of GHS-0.0 Mil. The current Other Long-Term Liabilities is GHS-0.0 Mil. Dannex Ayrton Starwin's overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Dannex Ayrton Starwin (XGHA:DASPHARMA), the current Other Long-Term Liabilities is GHS-0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dannex Ayrton Starwin Business Description

Comparable Companies
Address No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.
7GF Score

Get the complete analysis for XGHA:DASPHARMA

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS1.19
Price